117 related articles for article (PubMed ID: 2901850)
1. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
Sidi Y; Panet C; Wasserman L; Cyjon A; Novogrodsky A; Nordenberg J
Br J Cancer; 1988 Jul; 58(1):61-3. PubMed ID: 2901850
[No Abstract] [Full Text] [Related]
2. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
3. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
Malinoski F; Stollar V
Virology; 1981 Apr; 110(2):281-9. PubMed ID: 6111860
[No Abstract] [Full Text] [Related]
5. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
[No Abstract] [Full Text] [Related]
7. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
Kaiser WA; Herrmann B; Keppler DO
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the effects of rT3 and IMP dehydrogenase inhibitors on normal and trisomic 21 lymphocyte cultures.
Peeters M; Réthoré MO; de Kermadec S; Lejeune J
Ann Genet; 1989; 32(4):211-3. PubMed ID: 2575364
[TBL] [Abstract][Full Text] [Related]
9. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.
Cass CE; Lowe JK; Manchak JM; Henderson JF
Cancer Res; 1977 Sep; 37(9):3314-20. PubMed ID: 195725
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines.
Sidi Y; Beery E; Panet C; Wasserman L; Novogrodsky A; Nordenberg J
Eur J Cancer Clin Oncol; 1989 May; 25(5):883-9. PubMed ID: 2737221
[TBL] [Abstract][Full Text] [Related]
12. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
[TBL] [Abstract][Full Text] [Related]
13. IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.
Hupe DJ; Azzolina BA; Behrens ND
J Biol Chem; 1986 Jun; 261(18):8363-9. PubMed ID: 2873141
[TBL] [Abstract][Full Text] [Related]
14. Increases in purine excretion and rate of synthesis by drugs inhibiting IMP dehydrogenase or adenylosuccinate synthetase activities.
Willis RC; Seegmiller JE
Adv Exp Med Biol; 1979; 122B():237-41. PubMed ID: 44644
[No Abstract] [Full Text] [Related]
15. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
[TBL] [Abstract][Full Text] [Related]
16. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
Page JD; Chaney SG; Hall IH; Lee KH; Holbrook DJ
Biochim Biophys Acta; 1987 Nov; 926(2):186-94. PubMed ID: 2889474
[TBL] [Abstract][Full Text] [Related]
18. Two distinct target sites on IMP dehydrogenase in chemotherapy.
Yamada Y; Natsumeda Y; Yamaji Y; Weber G
Adv Exp Med Biol; 1989; 253B():57-63. PubMed ID: 2575352
[No Abstract] [Full Text] [Related]
19. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471
[No Abstract] [Full Text] [Related]
20. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
Lowe JK; Brox L; Henderson JF
Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
